MGI, Chiron Corp regulatory update

MOGN’s Salagen Tablets received marketing approval in France, Ireland and Greece. The tablets treat radiation-induced dry mouth in head and neck cancer patients. CHIR’s Chiron Therapeutics BV unit wi...